Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. WW
WW logo

WW Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy WW International Inc (WW) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
9.990
1 Day change
-2.06%
52 Week Range
105.210
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

WW International Inc is not a strong buy for a beginner, long-term investor at this moment. The company's financial performance is weak, with declining revenue, net income, and EPS. Technical indicators show a bearish trend, and there is no significant positive catalyst to suggest immediate growth. While options data indicates some bearish sentiment, there is no strong signal from Intellectia Proprietary Trading Signals to support a buy decision. Holding off on investment for now is recommended.

Technical Analysis

The MACD histogram is positive at 0.094, indicating slight bullish momentum, but the RSI at 29.117 is neutral. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its support level of 9.24. Overall, the technical indicators suggest a bearish trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
0

Positive Catalysts

  • Appointment of Heather Thiltgen to the Board of Directors, bringing healthcare leadership experience.

Neutral/Negative Catalysts

  • Declining financial performance in Q4 2025, with revenue down 11.71% YoY, net income down 123.22% YoY, and EPS down 287.10% YoY. Analysts have lowered price targets, citing mixed shifts in business strategy.

Financial Performance

In Q4 2025, revenue dropped to $162.81M (-11.71% YoY), net income fell to -$5.83M (-123.22% YoY), and EPS declined to -$0.58 (-287.10% YoY). Gross margin improved slightly to 69.99% (+1.33% YoY), but overall financials are weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Morgan Stanley lowered the price target from $34.50 to $21, maintaining an Equal Weight rating. Analysts note a faster-than-expected mix shift in business strategy, with both upsides and negative trade-offs.

Wall Street analysts forecast WW stock price to rise
1 Analyst Rating
Wall Street analysts forecast WW stock price to rise
0 Buy
1 Hold
0 Sell
Hold
Current: 10.200
sliders
Low
38
Averages
38
High
38
Current: 10.200
sliders
Low
38
Averages
38
High
38
Morgan Stanley
Equal Weight
downgrade
$21 -> $20
AI Analysis
2026-05-08
New
Reason
Morgan Stanley
Price Target
$21 -> $20
AI Analysis
2026-05-08
New
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on WW to $20 from $21 and keeps an Equal Weight rating on the shares.
Morgan Stanley
Equal Weight
downgrade
$21
2026-04-01
Reason
Morgan Stanley
Price Target
$21
2026-04-01
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on WW to $21 from $34.50 and keeps an Equal Weight rating on the shares. A mix shift from behavioral to clinic is happening far faster than the firm anticipated, but this comes with upside as well as "negative trade-offs," the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for WW
Unlock Now

People Also Watch